user

Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis

被引：1
|
作者：
Muthiah, Mark D. [1 ,2 ]
Siddiqui, Mohammad S. [3 ]
机构：
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore
[3] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 55卷 / 04期
关键词：
D O I：
10.1111/apt.16748
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：483 / 484
页数：2
相关论文
共 50 条
  • [1] Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis-authors' reply
    Safadi, Rifaat
    Braun, Marius
    Francis, Adi
    Milgrom, Yael
    Massarwa, Muhammad
    Hakimian, David
    Hazou, Wadi
    Issachar, Assaf
    Harpaz, Zivit
    Farbstein, Motti
    Itzhak, Inbal
    Lev-Cohain, Naama
    Bareket-Samish, Avital
    Silverman, Michael H.
    Fishman, Pnina
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (04) : 485 - 486
  • [2] Treatment of alcoholic and non-alcoholic steatohepatitis
    Stremmel, W
    Blechacz, B
    Herrmann, T
    Rost, D
    Mueller, S
    INTERNIST, 2001, 42 (12): : 1641 - +
  • [3] Treatment of non-alcoholic steatohepatitis
    Angulo, P
    Lindor, KD
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (05) : 797 - 810
  • [4] In Vivo Screening Towards Hepatic Stellate Cell Targeting in Non-Alcoholic Steatohepatitis
    Araki, Alex
    Jensen, Martin Borch
    Carrico, Chris
    Chio, Linda
    Dixit, Atray
    Driver, Ian
    Duwaerts, Caroline
    Fuentes, Daniel
    Kartha, Vinay
    Kuwahara, Akela
    LePort, Francisco
    Miyazaki, Hikaru
    Morgan, Wyatt
    Popov, Dimitry
    Shambhu, Smitha
    Towne, Chris
    MOLECULAR THERAPY, 2023, 31 (04) : 330 - 330
  • [5] CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
    Linling Ju
    Yan Sun
    Hong Xue
    Lin Chen
    Chunyan Gu
    Jianguo Shao
    Rujian Lu
    Xi Luo
    Jue Wei
    Xiong Ma
    Zhaolian Bian
    Scientific Reports, 10
  • [6] CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
    Ju, Linling
    Sun, Yan
    Xue, Hong
    Chen, Lin
    Gu, Chunyan
    Shao, Jianguo
    Lu, Rujian
    Luo, Xi
    Wei, Jue
    Ma, Xiong
    Bian, Zhaolian
    SCIENTIFIC REPORTS, 2020, 10 (01) : 3201
  • [7] Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non-Alcoholic Steatohepatitis
    Ipsen, David H.
    Rolin, Bidda
    Rakipovski, Guenaj
    Skovsted, Gry F.
    Madsen, Anette
    Kolstrup, Stefanie
    Schou-Pedersen, Anne Marie
    Skat-Rordam, Josephine
    Lykkesfeldt, Jens
    Tveden-Nyborg, Pernille
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (06) : 704 - 713
  • [8] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Thomas Klein
    Masato Fujii
    Jan Sandel
    Yuichiro Shibazaki
    Kyoko Wakamatsu
    Michael Mark
    Hiroyuki Yoneyama
    Medical Molecular Morphology, 2014, 47 : 137 - 149
  • [9] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Klein, Thomas
    Fujii, Masato
    Sandel, Jan
    Shibazaki, Yuichiro
    Wakamatsu, Kyoko
    Mark, Michael
    Yoneyama, Hiroyuki
    MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (03) : 137 - 149
  • [10] Role of hepatic iron in non-alcoholic steatohepatitis
    Sumida, Yoshio
    Yoshikawa, Toshikazu
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2009, 39 (03) : 213 - 222
12345